New spinocerebellar ataxia subtype caused by SAMD9L mutation triggering mitochondrial dysregulation (SCA49)

Spinocerebellar ataxias consist of a highly heterogeneous group of inherited movement disorders clinically characterized by progressive cerebellar ataxia variably associated with additional distinctive clinical signs. The genetic heterogeneity is evidenced by the myriad of associated genes and under...

Full description

Bibliographic Details
Authors: Corral-Juan, Marc|||0000-0001-9407-7516, Casquero, Pilar, Giraldo-Restrepo, Natalia, Laurie, Steven|||0000-0003-3913-5829, Martínez-Piñeiro, Alicia|||0000-0003-1988-606X, Mateo-Montero, Raidili Cristina, Ispierto, Lourdes, Vilas Rolán, Dolores|||0000-0003-3084-053X, Tolosa, Eduardo, Volpini, Víctor, Álvarez, Ramiro|||0000-0002-8053-7232, Sanchez, Ivelisse|||0000-0002-7605-5337, Matilla-Dueñas, Antoni|||0000-0002-3514-4181
Format: article
Publication Date:2022
Country:España
Institution:Universitat Autònoma de Barcelona
Repository:Dipòsit Digital de Documents de la UAB
Language:English
OAI Identifier:oai:ddd.uab.cat:258911
Online Access:https://ddd.uab.cat/record/258911
https://dx.doi.org/urn:doi:10.1093/braincomms/fcac030
Access Level:Open access
Keyword:Spinocerebellar ataxia
SAMD9L
SCA49
Mitochondria
Zebrafish
Description
Summary:Spinocerebellar ataxias consist of a highly heterogeneous group of inherited movement disorders clinically characterized by progressive cerebellar ataxia variably associated with additional distinctive clinical signs. The genetic heterogeneity is evidenced by the myriad of associated genes and underlying genetic defects identified. In this study, we describe a new spinocerebellar ataxia subtype in nine members of a Spanish five-generation family from Menorca with affected individuals variably presenting with ataxia, nystagmus, dysarthria, polyneuropathy, pyramidal signs, cerebellar atrophy and distinctive cerebral demyelination. Affected individuals presented with horizontal and vertical gaze-evoked nystagmus and hyperreflexia as initial clinical signs, and a variable age of onset ranging from 12 to 60 years. Neurophysiological studies showed moderate axonal sensory polyneuropathy with altered sympathetic skin response predominantly in the lower limbs. We identified the c.1877C.